Observational data collection on focal therapies for prostate cancer
Ablative Therapy in the Management of Prostate Cancer
This study is collecting information on different focal therapies for prostate cancer to see how well they work and how they affect patients' lives.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Weill Medical College of Cornell University Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT03492424 on ClinicalTrials.gov |
What this trial studies
This study aims to gather observational data on the patterns of care and outcomes associated with various focal therapies for prostate cancer, including high-intensity focused ultrasound, cryotherapy, and others. It will utilize both prospective and retrospective registry methods to collect detailed information on patient characteristics, treatment specifics, and oncologic outcomes. Safety and functional outcomes will also be assessed using established classification scales and quality of life questionnaires. The goal is to better understand the effectiveness and safety of these treatment options.
Who should consider this trial
Good fit: Ideal candidates for this study are men over 18 years old who are undergoing or have previously received focal therapy for prostate cancer.
Not a fit: Patients with clinically evident metastatic disease or those unable to complete an English-language questionnaire may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the effectiveness and safety of focal therapies for prostate cancer, potentially improving patient outcomes.
How similar studies have performed: Other studies have shown success with similar observational approaches in assessing treatment outcomes for prostate cancer, indicating that this methodology is both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * \>18 years of age * Undergoing focal therapy for primary or salvage treatment of prostate cancer, or * Have received prior focal therapy Exclusion Criteria: * Clinically-evident metastatic disease * Unable to fill out an English-language questionnaire
Where this trial is running
New York, New York
- Weill Cornell Medicine — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Tim McClure, M.D. — Weill Medical College of Cornell University
- Study coordinator: Holly Kuczynsk, BS
- Email: hok4001@med.cornell.edu
- Phone: 646-962-7523
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.